Inventor · disambiguated record
Rui Xu
Also filed as: XU RUI · XU RUI HENG
38 granted patents·29 pending applications·336 citations·filing 2001–2025
97Inventor score
Files withARRAY BIOPHARMA INC22PELOTON THERAPEUTICS INC12HANGZHOU POLYMED BIOPHARMACEUTICALS INC6MITCHELL IAN S6THERAS INC5
Top patents by PatentIndex Score
67 records- 0197US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 0295US10155726B2Substituted pyridines and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Dec 18, 2018·14 cites·24 claims
- 0395US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0494US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 0593USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 0693US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 0793US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 0893US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 0993US8324221B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 4, 2012·54 cites·60 claims
- 1092US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 1190US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 1289US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 1389US8377937B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Feb 19, 2013·15 cites·37 claims
- 1488US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 1587US8329701B2Dihydrofuro pyrimidines as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Dec 11, 2012·12 cites·27 claims
- 1687US8329709B25H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 11, 2012·10 cites·33 claims
- 1786US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 1883US12343343B2Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereofHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·0 cites·3 claims
- 1982US8618097B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsBENCSIK JOSEF·Filed 2008·Granted Dec 31, 2013·7 cites·48 claims
- 2081US10807948B2Aromatic compounds and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·18 claims
- 2181US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 2277US8853216B2Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitorBENCSIK JOSEF·Filed 2009·Granted Oct 7, 2014·3 cites·5 claims
- 2377US2022226326A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2477US2025152588A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2575US12281098B2Five-membered-fused six-membered compound, preparation method, pharmaceutical composition and useHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2024·Granted Apr 22, 2025·0 cites·3 claims
- 2675US8846683B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Sep 30, 2014·1 cites·35 claims
- 2774US2025368627A1Pyrazolesulfonamides as antitumor agentsPELOTON THERAPEUTICS INC A FULLY OWNED SUBSIDIARY OF MERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 2873US9409886B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 9, 2016·2 cites·50 claims
- 2973US6503922B2Bridged nicotine compounds for use in the treatment of CNS pathologiesUNIV KENTUCKY RES FOUND·Filed 2001·Granted Jan 7, 2003·7 cites·36 claims
- 3072US2020190031A1Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3171US9303040B2Substituted piperazines as AKT inhibitorsMITCHELL IAN S·Filed 2007·Granted Apr 5, 2016·1 cites·32 claims
- 3271US8895566B25H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 25, 2014·1 cites·34 claims
- 3371US8835434B2Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsBENCSIK JOSEF R·Filed 2009·Granted Sep 16, 2014·2 cites·2 claims
- 3471US2020345735A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3571US2025255864A1Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereofHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3671US2025255863A1Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereofHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3768US9546156B2N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jan 17, 2017·1 cites·25 claims
- 3864US2014315887A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 3964US2018169099A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 4063US7091357B2Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologiesUNIV KENTUCKY RES FOUND·Filed 2002·Granted Aug 15, 2006·4 cites·15 claims
- 4162US9328091B25H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted May 3, 2016·0 cites·3 claims
- 4260US2019015377A1Compositions for Use in Treating Pulmonary Arterial HypertensionPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4360US2016235754A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 4459US12195479B2Five- and six-membered compound, and preparation method therefor and pharmaceutical composition and use thereofHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2023·Granted Jan 14, 2025·0 cites·12 claims
- 4559US2022162193A1Pyrazolesulfonamides as antitumor agentsESTRADA MICHELLE ANN·Filed 2020·Application pending·0 cites
- 4658US7320857B2Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereofCHINESE NAT HUMAN GENOME CT SH·Filed 2004·Granted Jan 22, 2008·2 cites·6 claims
- 4758US2014349996A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 4857US2025214972A1Five-membered-fused six-membered compound, preparation method, pharmaceutical composition and useHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4956US2016152576A9Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 5055US12378564B2Tomato glutaredoxin SIGRXC9 gene and its applicationSANYA INSTITUTE OF HENAN UNIV·Filed 2022·Granted Aug 5, 2025·0 cites·7 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rui Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →